• 中国科技核心期刊
  • 中文科技期刊数据库刊源
  • 中国科技论文统计源期刊
  • 美国化学文摘社《化学文摘》刊源
Volume 34 Issue 3
May  2022
Turn off MathJax
Article Contents
Xiao-qin LIU, En-fa ZHAO, Hang XIE, Hao-wei ZENG, Ya-juan DU, Lu HE, Yu-shun ZHANG. Single-center experience of multidisciplinary assessment of patent foramen ovale in elderly patients and follow-up after device closure[J]. Chinese Heart Journal, 2022, 34(3): 280-284. doi: 10.12125/j.chj.202107085
Citation: Xiao-qin LIU, En-fa ZHAO, Hang XIE, Hao-wei ZENG, Ya-juan DU, Lu HE, Yu-shun ZHANG. Single-center experience of multidisciplinary assessment of patent foramen ovale in elderly patients and follow-up after device closure[J]. Chinese Heart Journal, 2022, 34(3): 280-284. doi: 10.12125/j.chj.202107085

Single-center experience of multidisciplinary assessment of patent foramen ovale in elderly patients and follow-up after device closure

doi: 10.12125/j.chj.202107085
  • Received Date: 2021-07-28
  • Rev Recd Date: 2021-11-15
  • Publish Date: 2022-05-26
  •   AIM  To explore the safety and efficacy of transcatheter patent foramen ovale (PFO) occlusion in the treatment of high-risk PFO in the elderly patients on the basis of multidisciplinary evaluation.   METHODS  Included in this study were the elderly patients admitted to our department from March 2014 to December 2020, who were diagnosed as having embolic strokes of undetermined source or transient ischemic attack (TIA) with high-risk PFO and received PFO closure. All the patients underwent multidisciplinary evaluation before the operation to rule out stroke/TIA that had a clear cause or other possible factors and after the operation the patients were followed up for complications and recurrent ischemic events.   RESULTS  A total of 122 patients were enrolled (average age of 64(5)years) with mean follow-up time of 2.5±1.7 years. Two kinds of occluders were used in the study and there was no difference in the endpoint events between the two occluders and no serious adverse events occurred. The annual risk of recurrent ischemic stroke/TIA after PFO closure in elderly patients was 0.67%.   CONCLUSION  It is safe and effective for high-risk elderly PFO patients to undergo transcatheter PFO closure after strict multidisciplinary evaluation. Such patients can be treated with percutaneous patent foramen ovale occlusion to prevent recurrence of cerebrovascular events.

     

  • loading
  • [1]
    Lee PH, Song JK, Kim JS, et al. Cryptogenic stroke and high-risk patent foramen ovale: The DEFENSE-PFO trial[J]. J Am Coll Cardiol, 2018, 71(20): 2335 – 2342. doi: 10.1016/j.jacc.2018.02.046
    [2]
    Mas JL, Derumeaux G, Guillon B, et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke[J]. N Engl J Med, 2017, 377(11): 1011 – 1021. doi: 10.1056/NEJMoa1705915
    [3]
    Saver JL, Carroll JD, Thaler DE, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke[J]. N Engl J Med, 2017, 377(11): 1022 – 1032. doi: 10.1056/NEJMoa1610057
    [4]
    Søndergaard L, Kasner SE, Rhodes JF, et al. Patent foramen pvale closure or antiplatelet therapy for cryptogenic stroke[J]. N Engl J Med, 2017, 377(11): 1033 – 1042. doi: 10.1056/NEJMoa1707404
    [5]
    Kuijpers T, Spencer FA, Siemieniuk RAC, et al. Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? a clinical practice guideline[J]. BMJ, 2018, 362: k2515. doi: 10.1136/bmj.k2515
    [6]
    Pristipino C, Sievert H, D'Ascenzo F, et al. European position paper on the management of patients with patent foramen ovale. general approach and left circulation thromboembolism[J]. Eur Heart J, 2019, 40(38): 3182 – 3195. doi: 10.1093/eurheartj/ehy649
    [7]
    Mazzucco S, Li L, Rothwell PM. Prognosis of cryptogenic stroke with patent foramen ovale at older ages and implications for trials: a population-based study and systematic review[J]. JAMA Neurol, 2020, 77(10): 1279 – 1287. doi: 10.1001/jamaneurol.2020.1948
    [8]
    Kwon H, Lee PH, Song JK, et al. Patent foramen ovale closure in old stroke patients: a subgroup analysis of the DEFENSE-PFO trial[J]. J Stroke, 2021, 23(2): 289 – 292. doi: 10.5853/jos.2021.00647
    [9]
    Hart RG, Diener HC, Coutts SB, et al. Embolic strokes of undetermined source: the case for a new clinical construct[J]. Lancet Neurol, 2014, 13(4): 429 – 438. doi: 10.1016/S1474-4422(13)70310-7
    [10]
    Kim BJ, Sohn H, Sun BJ, et al. Imaging characteristics of ischemic strokes related to patent foramen ovale[J]. Stroke, 2013, 44(12): 3350 – 3356. doi: 10.1161/STROKEAHA.113.002459
    [11]
    张玉顺, 蒋世良, 朱鲜阳. 卵圆孔未闭相关卒中预防中国专家指南[J]. 心脏杂志, 2021, 33(1): 1 – 10. doi: 10.12125/j.chj.202101022
    [12]
    Spies C, Khandelwal A, Timmemanns I, et al. Recurrent events following patent foramen ovale closure in patients above 55 years of age with presumed paradoxical embolism[J]. Catheter Cardiovasc Interv, 2008, 72(7): 966 – 970. doi: 10.1002/ccd.21737
    [13]
    Takafuji H, Hosokawa S, Ogura R, et al. Percutaneous transcatheter closure of high-risk patent foramen ovale in the elderly[J]. Heart Vessels, 2019, 34(10): 1657 – 1662. doi: 10.1007/s00380-019-01379-0
    [14]
    Wintzer-Wehekind J, Alperi A, Houde C, et al. Transcatheter closure of patent foramen ovale in patients older than 60 years of age with cryptogenic embolism[J]. Rev Esp Cardiol (Engl Ed), 2020, 73(3): 219 – 224. doi: 10.1016/j.rec.2019.07.003
    [15]
    Luermans JG, Budts W, Ten Berg JM, et al. Comparison of outcome after patent foramen ovale closure in older versus younger patients[J]. EuroIntervention, 2011, 7(2): 209 – 215. doi: 10.4244/EIJV7I2A35
    [16]
    Scacciatella P, Meynet I, Presbitero P, et al. Recurrent cerebral ischemia after patent foramen ovale percutaneous closure in older patients: a two-center registry study[J]. Catheter Cardiovasc Interv, 2016, 87(3): 508 – 514. doi: 10.1002/ccd.26053
    [17]
    Pristipino C, Anzola GP, Ballerini L, et al. Management of patients with patent foramen ovale and cryptogenic stroke: a collaborative, multidisciplinary, position paper: executive summary[J]. Catheter Cardiovasc Interv, 2013, 82(1): 122 – 129. doi: 10.1002/ccd.24693
    [18]
    Ricci B, Chang AD, Hemendinger M, et al. A simple score that predicts paroxysmal atrial fibrillation on outpatient cardiac monitoring after embolic stroke of unknown source[J]. J Stroke Cerebrovasc Dis, 2018, 27(6): 1692 – 1696. doi: 10.1016/j.jstrokecerebrovasdis.2018.01.028
    [19]
    Andreozzi GM, Verlato F. [Superficial thrombophlebitis][J]. Minerva Cardioangiol, 2000, 48(12 Suppl 1): 9 – 14.
    [20]
    Merkler AE, Gialdini G, Yaghi S, et al. Safety outcomes after percutaneous transcatheter closure of patent foramen ovale[J]. Stroke, 2017, 48(11): 3073 – 3077. doi: 10.1161/STROKEAHA.117.018501
    [21]
    Germonpre P, Hastir F, Dendale P, et al. Evidence for increasing patency of the foramen ovale in divers[J]. Am J Cardiol, 2005, 95(7): 912 – 915. doi: 10.1016/j.amjcard.2004.12.026
    [22]
    Mir H, Siemieniuk RAC, Ge L, et al. Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence[J]. BMJ Open, 2018, 8(7): e023761. doi: 10.1136/bmjopen-2018-023761
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(4)

    Article views (119) PDF downloads(10) Cited by()
    Proportional views

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return